The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Trends Update — IP Constituencies: Sanofi Buys Medley in Brazil

Continuing a trend we have been following of increased “innovator” pharma investment in global generics and biosimilars, Sanofi-Aventis is spending €500 million to acquire Medley, a  privately-held Brazilian manufacturer. The acquisition will make Sanofi Latin America’s biggest generics manufacturer.  A post at the WSJ Health Blog on the acquisition includes a nice overview of the other recent pharma-generics deals.

Bookmark and Share

About these ads

3 responses to “Trends Update — IP Constituencies: Sanofi Buys Medley in Brazil

  1. Pingback: Top Four Biotech Trends of 2009 « The Cross-Border Biotech Blog

  2. Pingback: Patent Cliff Will Not Save Biotech: Abbott Buys Indian Generics Company Piramal Healthcare « The Cross-Border Biotech Blog

  3. Pingback: Patent cliff will not save biotech « The RIC Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers